These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 10390205

  • 1. DNA cleavage activities of Staphylococcus aureus gyrase and topoisomerase IV stimulated by quinolones and 2-pyridones.
    Saiki AY, Shen LL, Chen CM, Baranowski J, Lerner CG.
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1574-7. PubMed ID: 10390205
    [Abstract] [Full Text] [Related]

  • 2. Activities of trovafloxacin compared with those of other fluoroquinolones against purified topoisomerases and gyrA and grlA mutants of Staphylococcus aureus.
    Gootz TD, Zaniewski RP, Haskell SL, Kaczmarek FS, Maurice AE.
    Antimicrob Agents Chemother; 1999 Aug; 43(8):1845-55. PubMed ID: 10428901
    [Abstract] [Full Text] [Related]

  • 3. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
    Blanche F, Cameron B, Bernard FX, Maton L, Manse B, Ferrero L, Ratet N, Lecoq C, Goniot A, Bisch D, Crouzet J.
    Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
    [Abstract] [Full Text] [Related]

  • 4. Action of quinolones against Staphylococcus aureus topoisomerase IV: basis for DNA cleavage enhancement.
    Anderson VE, Zaniewski RP, Kaczmarek FS, Gootz TD, Osheroff N.
    Biochemistry; 2000 Mar 14; 39(10):2726-32. PubMed ID: 10704224
    [Abstract] [Full Text] [Related]

  • 5. Streptococcus pneumoniae DNA gyrase and topoisomerase IV: overexpression, purification, and differential inhibition by fluoroquinolones.
    Pan XS, Fisher LM.
    Antimicrob Agents Chemother; 1999 May 14; 43(5):1129-36. PubMed ID: 10223925
    [Abstract] [Full Text] [Related]

  • 6. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
    Strahilevitz J, Robicsek A, Hooper DC.
    Antimicrob Agents Chemother; 2006 Feb 14; 50(2):600-6. PubMed ID: 16436716
    [Abstract] [Full Text] [Related]

  • 7. Quinolones inhibit DNA religation mediated by Staphylococcus aureus topoisomerase IV. Changes in drug mechanism across evolutionary boundaries.
    Anderson VE, Zaniewski RP, Kaczmarek FS, Gootz TD, Osheroff N.
    J Biol Chem; 1999 Dec 10; 274(50):35927-32. PubMed ID: 10585479
    [Abstract] [Full Text] [Related]

  • 8. Inhibitory activities of quinolones against DNA gyrase and topoisomerase IV purified from Staphylococcus aureus.
    Tanaka M, Onodera Y, Uchida Y, Sato K, Hayakawa I.
    Antimicrob Agents Chemother; 1997 Nov 10; 41(11):2362-6. PubMed ID: 9371334
    [Abstract] [Full Text] [Related]

  • 9. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
    Fernandez-Moreira E, Balas D, Gonzalez I, de la Campa AG.
    Microb Drug Resist; 2000 Nov 10; 6(4):259-67. PubMed ID: 11272253
    [Abstract] [Full Text] [Related]

  • 10. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L, Cameron B, Manse B, Lagneaux D, Crouzet J, Famechon A, Blanche F.
    Mol Microbiol; 1994 Aug 10; 13(4):641-53. PubMed ID: 7997176
    [Abstract] [Full Text] [Related]

  • 11. The effect of moxifloxacin on its target topoisomerases from Escherichia coli and Staphylococcus aureus.
    Schedletzky H, Wiedemann B, Heisig P.
    J Antimicrob Chemother; 1999 May 10; 43 Suppl B():31-7. PubMed ID: 10382873
    [Abstract] [Full Text] [Related]

  • 12. Antibacterial activities and inhibitory effects of sitafloxacin (DU-6859a) and its optical isomers against type II topoisomerases.
    Akasaka T, Kurosaka S, Uchida Y, Tanaka M, Sato K, Hayakawa I.
    Antimicrob Agents Chemother; 1998 May 10; 42(5):1284-7. PubMed ID: 9593169
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
    Alt S, Mitchenall LA, Maxwell A, Heide L.
    J Antimicrob Chemother; 2011 Sep 10; 66(9):2061-9. PubMed ID: 21693461
    [Abstract] [Full Text] [Related]

  • 14. Target preference of 15 quinolones against Staphylococcus aureus, based on antibacterial activities and target inhibition.
    Takei M, Fukuda H, Kishii R, Hosaka M.
    Antimicrob Agents Chemother; 2001 Dec 10; 45(12):3544-7. PubMed ID: 11709337
    [Abstract] [Full Text] [Related]

  • 15. Quinolone resistance mutations in topoisomerase IV: relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus.
    Ng EY, Trucksis M, Hooper DC.
    Antimicrob Agents Chemother; 1996 Aug 10; 40(8):1881-8. PubMed ID: 8843298
    [Abstract] [Full Text] [Related]

  • 16. Purification of pneumococcal type II topoisomerases and inhibition by gemifloxacin and other quinolones.
    Morrissey I, George JT.
    J Antimicrob Chemother; 2000 Apr 10; 45 Suppl 1():101-6. PubMed ID: 10824040
    [Abstract] [Full Text] [Related]

  • 17. Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
    Strahilevitz J, Hooper DC.
    Antimicrob Agents Chemother; 2005 May 10; 49(5):1949-56. PubMed ID: 15855518
    [Abstract] [Full Text] [Related]

  • 18. Selective targeting of topoisomerase IV and DNA gyrase in Staphylococcus aureus: different patterns of quinolone-induced inhibition of DNA synthesis.
    Fournier B, Zhao X, Lu T, Drlica K, Hooper DC.
    Antimicrob Agents Chemother; 2000 Aug 10; 44(8):2160-5. PubMed ID: 10898691
    [Abstract] [Full Text] [Related]

  • 19. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
    Fournier B, Hooper DC.
    Antimicrob Agents Chemother; 1998 Jan 10; 42(1):121-8. PubMed ID: 9449271
    [Abstract] [Full Text] [Related]

  • 20. DNA gyrase of Staphylococcus aureus and inhibitory effect of quinolones on its activity.
    Takahata M, Nishino T.
    Antimicrob Agents Chemother; 1988 Aug 10; 32(8):1192-5. PubMed ID: 2847648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.